AN ENDURING COMMITMENT

For more than 25 years, Teva has demonstrated its commitment to relapsing MS (RMS) patients and the providers who administer their care.1

Proprietary manufacturing process

COPAXONE® is a mixture of potentially millions
of distinct polypeptide sequences.1,2

HOW IT’S MADE

Demonstrated efficacy1

Review clinical trial data for COPAXONE®.

LEARN ABOUT EFFICACY

Safety and tolerability

Review adverse reaction rates and tolerability
data for COPAXONE®.

LEARN ABOUT SAFETY

Simplified prescribing

Getting your patients started on COPAXONE® and giving them the tools for successful treatment has been streamlined. Teva Shared Solutions® has gone digital.

SEE WHAT’S NEW

References:

1.

COPAXONE® (glatiramer acetate injection) Current Prescribing Information Parsippany, NJ. Teva Neuroscience, Inc.

2.

Schellekens H, Klinger E, Mühlebach S, Brin J-F, Storm G, Crommelin DJA. The therapeutic equivalence of complex drugs. Regul Toxicol Pharmacol. 2011;59(1):176-183. doi:10.1016/j.yrtph.2010.09.021

You are about to leave COPAXONEHCP.com and enter a website operated by a third party.

Would you like to continue?

Allyable tool icon